IFNGR1 and neoplasm: Loss of YTHDF1 mediated overexpression of interferon (IFN)-γ receptor 1 (IFNGR1) and JAK/STAT1 signaling pathway in tumor cells, which might contribute to restored sensitivity to anti-tumor immunity.